Search research articles
Contact Us
Filters
Showing results (51-60 of 98) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy
Rebecca E Sadun, Suzanne M Sachsman, Xiaoying Chen, et al.
International Journal of Molecular Sciences
|
December 21, 2017
Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma
Long Zheng, Peisheng Hu, Brandon Wolfe, et al.
Scientific Reports
|
January 4, 2017
Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling
Prabhakaran Kumar, Khaled Alharshawi, Palash Bhattacharya, et al.
Cancer
|
March 23, 2011
Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity
Melissa G Lechner, Stephen Lade, Daniel J Liebertz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 18, 2019
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
Xiaojing Shi, Qinqin Cheng, Tianling Hou, et al.
Molecular Cancer Therapeutics
|
October 17, 2013
Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models
Julie K Jang, Leslie A Khawli, Ryan Park, et al.
Head & Neck Oncology
|
February 24, 2010
Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1
Daniel J Liebertz, Melissa G Lechner, Rizwan Masood, et al.
Scientific Reports
|
July 28, 2017
PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells
Khaled Alharshawi, Alejandra Marinelarena, Prabhakaran Kumar, et al.
Expert Review of Anticancer Therapy
|
August 27, 2014
Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA
Ruth A Bryan, Zewei Jiang, Thomas Jandl, et al.
Journal for Immunotherapy of Cancer
|
February 18, 2016
Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant
Brian M Andersen, Junzhe Xia, Alan L Epstein, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 98) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy
Rebecca E Sadun, Suzanne M Sachsman, Xiaoying Chen, et al.
International Journal of Molecular Sciences
|
December 21, 2017
Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma
Long Zheng, Peisheng Hu, Brandon Wolfe, et al.
Scientific Reports
|
January 4, 2017
Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling
Prabhakaran Kumar, Khaled Alharshawi, Palash Bhattacharya, et al.
Cancer
|
March 23, 2011
Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity
Melissa G Lechner, Stephen Lade, Daniel J Liebertz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 18, 2019
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
Xiaojing Shi, Qinqin Cheng, Tianling Hou, et al.
Molecular Cancer Therapeutics
|
October 17, 2013
Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models
Julie K Jang, Leslie A Khawli, Ryan Park, et al.
Head & Neck Oncology
|
February 24, 2010
Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1
Daniel J Liebertz, Melissa G Lechner, Rizwan Masood, et al.
Scientific Reports
|
July 28, 2017
PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells
Khaled Alharshawi, Alejandra Marinelarena, Prabhakaran Kumar, et al.
Expert Review of Anticancer Therapy
|
August 27, 2014
Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA
Ruth A Bryan, Zewei Jiang, Thomas Jandl, et al.
Journal for Immunotherapy of Cancer
|
February 18, 2016
Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant
Brian M Andersen, Junzhe Xia, Alan L Epstein, et al.
Page
of 10